What the study tracked
Researchers at Harvard Medical School followed people at risk of Alzheimer's disease for about nine years. Participants took cognitive tests every year and had brain scans repeated during the study. The scans tracked amyloid beta, a protein that builds up early, and tau, which forms tangles later as the disease progresses.
The team, led by behavioral neurologist Jasmeer Chhatwal, compared people by how much they walked. The results appeared in Nature Medicine and were reported by Science News.
Small amounts of movement counted
People who walked 3,000 to 5,000 steps a day had about 40 percent less cognitive decline than those who walked less than 3,000. In time terms, that looked like a delay of about three years. Those who walked 5,000 to 7,500 steps a day appeared to gain as much as seven years.
Activity also showed up in the scans. People who walked more built up less tau over time. Less tau generally meant better scores on the cognitive tests.
The step counts are low by fitness standards. Ten thousand steps a day is a common target, and many older adults never reach it. The study suggests that the first few thousand steps carry a large share of the benefit.
What it does not prove
This was an observational study. People who walk more may differ in other ways, from diet to income to overall health, and the researchers cannot rule out that something else explains part of the effect. A trial that assigns people to walking programs would give a firmer answer, and none has run long enough to measure dementia risk.
Even so, the finding fits earlier work linking exercise to slower brain aging. Walking is free, needs no equipment and carries little risk for most older adults. For people worried about memory, the practical message is that movement does not need to be intense or long to matter.